We are live on ! Find out more
AP

Antipodes Partners Portfolio holdings

AUM $5.19B
1-Year Est. Return 36.17%
This Fund
S&P 500
This Quarter Est. Return
-15.83%
1 Year Est. Return
+36.17%
3 Year Est. Return
+104%
5 Year Est. Return
+169.34%
10 Year Est. Return
AUM
$1.91B
AUM Growth
-$309M
Cap. Flow
+$19.3M
Cap. Flow %
1.01%
Top 10 Hldgs %
54.71%
Holding
36
New
6
Increased
13
Reduced
13
Closed
3

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$153M
2
JD icon
JD.com
JD
+$66.3M
3
FTI icon
TechnipFMC
FTI
+$57.7M
4
LOW icon
Lowe's Companies
LOW
+$41M
5
AMZN icon
Amazon
AMZN
+$39.8M

Top Sells

Rank Stock Value
1
EXPE icon
Expedia Group
EXPE
+$64M
2
UBER icon
Uber
UBER
+$42.9M
3
GILD icon
Gilead Sciences
GILD
+$42.8M
4
OC icon
Owens Corning
OC
+$42.5M
5
BABA icon
Alibaba
BABA
+$36.9M

Sector Composition

Rank Sector Weight
1 Technology 26.82%
2 Consumer Discretionary 25.76%
3 Healthcare 16.68%
4 Industrials 7.13%
5 Consumer Staples 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.35T
$164M 8.58%
1,039,527
-138,020
-12% -$22.7M
BABA icon
2
Alibaba
BABA
$279B
$144M 7.53%
740,195
-176,553
-19% -$36.9M
MRK icon
3
Merck
MRK
$321B
$143M 7.46%
+1,941,515
New +$153M
YUMC icon
4
Yum China
YUMC
$15.9B
$106M 5.54%
2,484,886
-103,193
-4% -$4.6M
GE icon
5
GE Aerospace
GE
$368B
$86.3M 4.52%
2,181,311
-586,614
-21% -$31.3M
B
6
Barrick Mining
B
$63.2B
$86.2M 4.51%
4,702,746
-855,974
-15% -$16M
UBER icon
7
Uber
UBER
$143B
$85.7M 4.48%
3,068,083
-1,304,822
-30% -$42.9M
QCOM icon
8
Qualcomm
QCOM
$160B
$80.3M 4.2%
1,187,685
+54,643
+5% +$4.48M
COF icon
9
Capital One
COF
$129B
$79.8M 4.18%
1,583,094
+338,322
+27% +$29.7M
KO icon
10
Coca-Cola
KO
$381B
$70.8M 3.71%
1,600,940
+588,624
+58% +$31.8M
LOW icon
11
Lowe's Companies
LOW
$118B
$69.7M 3.65%
810,535
+374,882
+86% +$41M
CSCO icon
12
Cisco
CSCO
$448B
$69.6M 3.64%
1,771,594
-782,511
-31% -$34.3M
STX icon
13
Seagate
STX
$193B
$68.7M 3.6%
1,408,171
+413,894
+42% +$22.1M
JD icon
14
JD.com
JD
$43.6B
$68.3M 3.57%
1,686,387
+1,660,164
+6,331% +$66.3M
MDT icon
15
Medtronic
MDT
$110B
$66.7M 3.49%
739,887
+134,412
+22% +$14.3M
GILD icon
16
Gilead Sciences
GILD
$163B
$66.6M 3.48%
890,367
-618,729
-41% -$42.8M
FTI icon
17
TechnipFMC
FTI
$27.5B
$62M 3.24%
12,353,157
+5,253,009
+74% +$57.7M
PEP icon
18
PepsiCo
PEP
$191B
$50.2M 2.63%
417,938
-3,567
-0.8% -$482K
META icon
19
Meta Platforms (Facebook)
META
$1.37T
$49.5M 2.59%
296,564
-18,685
-6% -$3.66M
QRVO icon
20
Qorvo
QRVO
$8.01B
$44.1M 2.31%
547,363
+130,488
+31% +$13.1M
AMZN icon
21
Amazon
AMZN
$2.53T
$40.1M 2.1%
+411,440
New +$39.8M
COR icon
22
Cencora
COR
$60.7B
$39.8M 2.08%
+449,911
New +$39.6M
TPR icon
23
Tapestry
TPR
$30.8B
$34.5M 1.81%
2,665,769
+198,991
+8% +$4.66M
TMUS icon
24
T-Mobile US
TMUS
$186B
$26.7M 1.4%
+317,976
New +$26.9M
EFX icon
25
Equifax
EFX
$20.7B
$26.2M 1.37%
219,159
-100,244
-31% -$14.6M

Similar funds

Antipodes Partners's Q1 2020 Portfolio in Review

As of Q1 2020, Antipodes Partners held 36 positions worth $1.91B, down 14% from $2.22B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Antipodes Partners's Q1 2020 filing shows 6 new, 13 increased, 13 reduced and 3 closed positions. Its largest new stake was Merck: 1,941,515 shares worth $143M. The largest sale was Expedia Group, an estimated $64M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Antipodes Partners's largest Q1 2020 buy was Merck: 1,941,515 shares worth $143M.
  • Antipodes Partners added most to JD.com in Q1 2020, an estimated $66.3M increase.
  • Antipodes Partners's biggest Q1 2020 reduction was Uber, cutting an estimated $42.9M.
  • Antipodes Partners fully exited Expedia Group in Q1 2020, selling an estimated $64M.
  • Antipodes Partners's ten largest holdings make up 55% of its $1.91B portfolio in Q1 2020.
  • Antipodes Partners opened 6 new positions and closed 3 in Q1 2020.
  • Antipodes Partners's portfolio value fell 14% quarter-over-quarter to $1.91B.

Based on Antipodes Partners's 13F filing for Q1 2020, filed 7 May 2020.